DrKieran Brennan

Research Fellow

School of Biomolecular and Biomedical Science

  • Research Fellow
    School of Biomolecular and Biomedical Science
  • 0877549288
  • University College Dublin, School of Biomolecular and Biomedical Science, Conway Institute Belfield Dublin 4

RESEARCH INTERESTS

Multiple Myeloma is the second most common haematological malignancy, affecting 6.5/100,000 people per year in the USA, while in Ireland approximately 361 people are diagnosed annually. Despite demonstrated therapeutic benefit of Daratumumab (DARA) in clinical practice ultimately all MM patients undergo relapse and progression. Thus, MM remains an incurable malignancy with a 5-years survival rate of around 40%. The major
unmet need is effective predictors of therapy response, which is my research is focused on Extracellular vesicles (EVs) as a promising non-invasive biomarkers that may aid in the diagnosis and risk-stratification of myeloma. my goal is the clinical validation of a non-invasive liquid biopsy biomarker panel that will advance understanding in the field and contribute towards implementation of precision medicine for myeloma.